Gary Berman

Gary Berman has over 15 years of experience in the healthcare industry, with a focus on medical devices and pharmaceuticals. Gary is currently the President of US Operations at Equinox, a leading provider of innovative therapies. Prior to joining Equinox, Gary was the Chief Business Officer and Chief Financial Officer at Breathe Technologies, Inc., a venture-backed medical device company that developed and commercialized innovative therapies for patients with COPD. Under Gary's leadership, the company was sold to Hillrom.

Gary started their career in investment banking at JP Morgan, before moving into corporate development and M&A at Ovation Pharmaceuticals. Gary then joined Egon Zehnder International as an Associate. In their most recent role before joining Equinox, Gary was responsible for leading the corporate development efforts at Breathe Technologies.

Gary holds a BA from the University of Pennsylvania and an MBA from Harvard Business School.

Gary Berman received a BA in Economics and Finance from Washington University in St. Louis.

They are on a team with Paul Yoo - Chief Scientific Officer, Matt Larson - Global President & Chief Operating Officer. Gary Berman reports to John Berdahl, Founder, CEO, Board Member.